Ventracor is a global medical device company which produces an implantable blood pump, the VentrAssist® left ventricular assist device (LVAD).
Ventracor is dedicated to building partnerships with healthcare professionals to make the VentrAssist the standard-of-care worldwide.
The VentrAssist® LVAD is a new third generation implantable blood pump primarily designed as an alternative to heart transplantation for people with heart failure.
It may also be used for patients waiting for heart transplants as a bridge to transplant or as a bridge to recovery.
"Our vision is to become the world’s major supplier of cardiac assist systems and to improve the quality of life for people suffering congestive heart failure"
Ventracor Limited is listed on the Australian Stock Exchange (symbol ASX: VCR) and on the New York Stock Exchange in the form of American Depository Shares (symbol: VTCRY).
|
